Advertisement

Topics

Does Sequential vs Concurrent Treatment Change Outcomes in HER2+ Breast Cancer?

06:25 EDT 15 Sep 2018 | Cancer Networks

Outcomes for patients with HER2-positive breast cancer did not differ when treated with sequential chemotherapy plus trastuzumab compared with a concurrent approach.

Original Article: Does Sequential vs Concurrent Treatment Change Outcomes in HER2+ Breast Cancer?

NEXT ARTICLE

More From BioPortfolio on "Does Sequential vs Concurrent Treatment Change Outcomes in HER2+ Breast Cancer?"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...